VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 104,219 | -5.5% | 0.00% | – |
| Q3 2022 | $17,000 | -88.1% | 110,298 | +23.5% | 0.00% | – |
| Q2 2022 | $143,000 | – | 89,307 | +40128.4% | 0.00% | – |
| Q3 2019 | $0 | – | 222 | -58.3% | 0.00% | – |
| Q2 2019 | $0 | – | 533 | +2.1% | 0.00% | – |
| Q1 2019 | $0 | – | 522 | -9.5% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 577 | -83.9% | 0.00% | – |
| Q2 2018 | $7,000 | +75.0% | 3,577 | +403.8% | 0.00% | – |
| Q3 2017 | $4,000 | -50.0% | 710 | -61.3% | 0.00% | – |
| Q2 2017 | $8,000 | – | 1,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |